Detalles de la búsqueda
1.
PET/CT imaging for evaluation of multimodal treatment efficacy and toxicity in advanced NSCLC-current state and future directions.
Eur J Nucl Med Mol Imaging
; 48(12): 3975-3989, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33760957
2.
External Validation of a Survival Score for Limited-Stage Small Cell Lung Cancer Patients Treated with Chemoradiotherapy.
Lung
; 198(1): 201-206, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31897594
3.
Medulloblastoma in adults : A retrospective single institution analysis.
Strahlenther Onkol
; 194(3): 225-234, 2018 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-29147840
4.
Correction to: Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.
Strahlenther Onkol
; 194(4): 363-364, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29541791
5.
Analysis of primary tumor metabolic volume during chemoradiotherapy in locally advanced non-small cell lung cancer.
Strahlenther Onkol
; 194(2): 107-115, 2018 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-29116336
6.
How much primary tumor metabolic volume reduction is required to improve outcome in stage III NSCLC after chemoradiotherapy? A single-centre experience.
Eur J Nucl Med Mol Imaging
; 45(12): 2103-2109, 2018 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-29876620
7.
Prognostic role of patient gender in limited-disease small-cell lung cancer treated with chemoradiotherapy.
Strahlenther Onkol
; 193(2): 150-155, 2017 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-27853828
8.
Evaluation of the role of remission status in a heterogeneous limited disease small-cell lung cancer patient cohort treated with definitive chemoradiotherapy.
BMC Cancer
; 16: 216, 2016 Mar 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-26975407
9.
Feasibility of hypofractionated radiotherapy in inoperable node-positive NSCLC patients with poor prognostic factors and limited pulmonary reserve: a prospective observational study.
Acta Oncol
; 60(8): 1074-1078, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34155956
10.
Multimodal "synergistic" treatment based on tumour immunological contexture for advanced non-driver non-small cell lung cancer: A myth or reality?
Eur J Cancer Care (Engl)
; 29(5): e13291, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32705732
11.
Why is survival after pembrolizumab affected by previous radiotherapy?
Lancet Oncol
; 18(9): e504, 2017 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-28884692
12.
Is it time to convert the frequency of radiotherapy in small-cell lung cancer?
Lancet Oncol
; 18(10): e555, 2017 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-28971814
13.
Radiation necrosis after a combination of external beam radiotherapy and iodine-125 brachytherapy in gliomas.
Radiat Oncol
; 16(1): 40, 2021 Feb 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33622365
14.
Implementation of durvalumab maintenance treatment after concurrent chemoradiotherapy in inoperable stage III non-small cell lung cancer (NSCLC)-a German radiation oncology survey.
Transl Lung Cancer Res
; 9(2): 288-293, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32420068
15.
Chemoradioimmunotherapy of inoperable stage III non-small cell lung cancer: immunological rationale and current clinical trials establishing a novel multimodal strategy.
Radiat Oncol
; 15(1): 167, 2020 Jul 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32646443
16.
Association of Planning Target Volume with Patient Outcome in Inoperable Stage III NSCLC Treated with Chemoradiotherapy: A Comprehensive Single-Center Analysis.
Cancers (Basel)
; 12(10)2020 Oct 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-33086481
17.
Blood Parameters Demonstrating a Significant Survival Impact in Patients With Locally Advanced NSCLC Undergoing Definitive Chemoradiotherapy.
Anticancer Res
; 40(4): 2319-2322, 2020 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-32234932
18.
Pattern-of-failure and salvage treatment analysis after chemoradiotherapy for inoperable stage III non-small cell lung cancer.
Radiat Oncol
; 15(1): 148, 2020 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32517716
19.
Stereotactic radiosurgery combined with targeted/ immunotherapy in patients with melanoma brain metastasis.
Radiat Oncol
; 15(1): 37, 2020 Feb 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-32059731
20.
Maximum standardized uptake value of primary tumor (SUVmax_PT) and horizontal range between two most distant PET-positive lymph nodes predict patient outcome in inoperable stage III NSCLC patients after chemoradiotherapy.
Transl Lung Cancer Res
; 9(3): 541-548, 2020 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-32676318